Colon primary cancer with metastatic

Colon primary cancer with metastatic 

To Order Contact us: lieven@wlsolutions.be

Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Colon

T6235090-PM 5 slides x2
EUR 736

Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Colon

T8235090-PM 5 slides x2
EUR 626

Ovary primary carcinoma with matched metastatic carcinoma tissue array

OV812 each
EUR 270
Description: Ovary primary carcinoma with matched metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 40 cases/80 cores

Cancer Antigen CEA Antigen (Human Metastatic Liver of Colon Adenocarcinoma)

VAng-Wyb8646-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver of Colon Adenocarcinoma, 7.8 mg/mL.

Lung cancer tissue array with matched metastatic lymph node

LC814a each
EUR 306
Description: Lung cancer tissue array with matched metastatic lymph node, 40 cases/80 cores, replacing LC814

Breast cancer with matched metastatic carcinoma or breast tissue array

BRM961a each
EUR 384
Description: Breast cancer with matched metastatic carcinoma or breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 49 cases/96 cores

Lung cancer with matched lymph node metastatic carcinoma tissue array

LC817b each
EUR 258
Description: Lung cancer with matched lymph node metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing LC817a

Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue

LC953 each
EUR 1434
Description: Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue, including TNM, clinical stage, pathology grade and survival data, 30 cases/95 cores, replacing LC952

Breast cancer with matched metastatic carcinoma of lymph node tissue array

BR1005b each
EUR 306
Description: Breast cancer with matched metastatic carcinoma of lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1005a

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Lung

D8235152-PM-10 2x10 ug
EUR 690

Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue

CO952a each
EUR 1434
Description: Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores.

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Liver

D8235149-PM-10 2x10 ug
EUR 690

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Breast

D8235086-PM-10 2x10 ug
EUR 690

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Kidney

D8235142-PM-10 2x10 ug
EUR 690

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Rectum

D8235206-PM-10 2x10 ug
EUR 690

Cervix cancer and normal tissue array with CIN and metastatic carcinoma

CR208 each
EUR 546
Description: Cervix cancer and normal tissue array with CIN and metastatic carcinoma, including pathology grade, TNM and clinical stage, 69 cases/207 cores

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Stomach

D8235248-PM-10 2x10 ug
EUR 690

Liver metastatic cancer tissue array

MLV801 each
EUR 354
Description: Liver metastatic cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores

Cancer of the cervix paired with metastatic tumors in lymph nodes, 12 cases (1.5mm)

CXM481 1
EUR 300
Description: Cervical cancer tissue array containing paired primary (in duplicates) and lymph node metastasis (in duplicates) from the same patients, 48 cores, 12 cases.

Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Lung

R8235152-PM-10 2x10 ug
EUR 716

Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Liver

R8235149-PM-10 2x10 ug
EUR 716

Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Breast

R8235086-PM-10 2x10 ug
EUR 716

Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Kidney

R8235142-PM-10 2x10 ug
EUR 716

Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Rectum

R8235206-PM-10 2x10 ug
EUR 716

Metastatic esophageal cancer tissue array

ES806 each
EUR 306
Description: Metastatic esophageal cancer tissue array, 40 cases/80 cores

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Liver

C8235149-PM 10 reactions x2
EUR 1102

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Lung

C8235152-PM 10 reactions x2
EUR 1102

Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Stomach

R8235248-PM-10 2x10 ug
EUR 716

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Breast

C8235086-PM 10 reactions x2
EUR 1102

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Kidney

C8235142-PM 10 reactions x2
EUR 1102

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Rectum

C8235206-PM 10 reactions x2
EUR 1102

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Stomach

C8235248-PM 10 reactions x2
EUR 1102

Multiple organ metastatic cancer tissue array

MT2081 each
EUR 474
Description: Multiple organ metastatic cancer tissue array, 19 organ/104 cases/208 cores

Cancer of the colon paired with metastasis, 48 cases (1.5mm)

COM961 1
EUR 433.2
Description: Colon metastatic cancer tissue array, 96 cores including 12 cases of colon cancers with matched adjacent normal tissues, 36 cases of colon cancers paired with lymph node metastasis.

Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma

KD951a each
EUR 1434
Description: Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases/95 cores,replacing KD951

Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Liver

P8235149-PM 0.2 mg x2
EUR 1325

Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Lung

P8235152-PM 0.2 mg x2
EUR 1325

Cancer Antigen CEA Antigen (Human Metastatic Liver)

VAng-Wyb8645-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver, 5.5 mg/mL.

Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Breast

P8235086-PM 0.2 mg x2
EUR 1325

Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Kidney

P8235142-PM 0.2 mg x2
EUR 1325

Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Rectum

P8235206-PM 0.2 mg x2
EUR 1325

Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Stomach

P8235248-PM 0.2 mg x2
EUR 1325

Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Lung

T6235152-PM 5 slides x2
EUR 736

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), 0.2mg/mL

BNUB3750-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), 0.2mg/mL

BNUB3750-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), 1mg/mL

BNUM3750-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Breast

T6235086-PM 5 slides x2
EUR 736

Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Kidney

T6235142-PM 5 slides x2
EUR 736

Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Liver

T6235149-PM 5 slides x2
EUR 736

Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Rectum

T6235206-PM 5 slides x2
EUR 1088

Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Lung

T8235152-PM 5 slides x2
EUR 626

Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Stomach

T6235248-PM 5 slides x2
EUR 736

Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Breast

T8235086-PM 5 slides x2
EUR 626

Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Kidney

T8235142-PM 5 slides x2
EUR 626

Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Liver

T8235149-PM 5 slides x2
EUR 626

Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Rectum

T8235206-PM 5 slides x2
EUR 626

Matched Pair - Paraffin Tissue Sections - Human Primary and Matched Metastatic Tumor (PM): Stomach

T8235248-PM 5 slides x2
EUR 626

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), 0.2mg/mL

BNUB2225-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), 0.2mg/mL

BNUB2225-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), 0.2mg/mL

BNUB2226-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), 0.2mg/mL

BNUB2226-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), 1mg/mL

BNUM2225-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), 1mg/mL

BNUM2226-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Breast cancer and matched metastatic carcinoma tissue array

BR10010f each
EUR 354
Description: Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade,IHC (ER,PR,Her-2,Ki67) markers results, 50 cases/100 cores, replacing BR10010e

Breast cancer and matched metastatic carcinoma tissue array

BR20837a each
EUR 546
Description: Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, 104 cases/ 208 cores, replacing BR20837

Malignant melanoma and metastatic malignant melanoma TMA with 6 matched cancer adjacent tissue samples

ME551 each
EUR 270
Description: Malignant melanoma and metastatic malignant melanoma TMA with 6 matched cancer adjacent tissue samples, including TNM and clinical stage (reference AJCC th version), 49cases/55 cores (core size 1.5mm) Recent Year Collection

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF640R conjugate, 0.1mg/mL

BNC403750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF640R conjugate, 0.1mg/mL

BNC403750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF647 conjugate, 0.1mg/mL

BNC473750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF647 conjugate, 0.1mg/mL

BNC473750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF405S conjugate, 0.1mg/mL

BNC043750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF405S conjugate, 0.1mg/mL

BNC043750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF568 conjugate, 0.1mg/mL

BNC683750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF568 conjugate, 0.1mg/mL

BNC683750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF488A conjugate, 0.1mg/mL

BNC883750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF488A conjugate, 0.1mg/mL

BNC883750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), Biotin conjugate, 0.1mg/mL

BNCB3750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), Biotin conjugate, 0.1mg/mL

BNCB3750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF594 conjugate, 0.1mg/mL

BNC943750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF594 conjugate, 0.1mg/mL

BNC943750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cancer Antigen CA 19-9 Antigen (Human metastatic liver carcinoma)

VAng-Wyb8635-inquire inquire Ask for price
Description: CA 19-9 (Gastrointestinal Cancer), Antigen Grade, Cancer antigen from Human metastatic liver carcinoma, 2900.0 kIU/mL.

Metastatic Tumor Tissue Array - 18 cases of metastatic cancers from 4 anatomic sites

Z7020073 5 slides
EUR 1125.6
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Metastatic Tumor Tissue Array - 48 cases of metastatic cancers from 8 anatomic sites

Z7020074 5 slides
EUR 1657.2
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF647 conjugate, 0.1mg/mL

BNC472225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF647 conjugate, 0.1mg/mL

BNC472225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF647 conjugate, 0.1mg/mL

BNC472226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF647 conjugate, 0.1mg/mL

BNC472226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF568 conjugate, 0.1mg/mL

BNC682225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF568 conjugate, 0.1mg/mL

BNC682225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF568 conjugate, 0.1mg/mL

BNC682226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF568 conjugate, 0.1mg/mL

BNC682226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF594 conjugate, 0.1mg/mL

BNC942225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF594 conjugate, 0.1mg/mL

BNC942225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF594 conjugate, 0.1mg/mL

BNC942226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF594 conjugate, 0.1mg/mL

BNC942226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

PC-3 Human prostate cancer cells derived from metastatic cancer cell line: >1x10^10 frozen exosomes

EXOP-115A-1 50 ug
EUR 409

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF640R conjugate, 0.1mg/mL

BNC402225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF640R conjugate, 0.1mg/mL

BNC402225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF640R conjugate, 0.1mg/mL

BNC402226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF640R conjugate, 0.1mg/mL

BNC402226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF488A conjugate, 0.1mg/mL

BNC882225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF488A conjugate, 0.1mg/mL

BNC882225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF488A conjugate, 0.1mg/mL

BNC882226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF488A conjugate, 0.1mg/mL

BNC882226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF405S conjugate, 0.1mg/mL

BNC042225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF405S conjugate, 0.1mg/mL

BNC042225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF405S conjugate, 0.1mg/mL

BNC042226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF405S conjugate, 0.1mg/mL

BNC042226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), Biotin conjugate, 0.1mg/mL

BNCB2225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), Biotin conjugate, 0.1mg/mL

BNCB2225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), Biotin conjugate, 0.1mg/mL

BNCB2226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), Biotin conjugate, 0.1mg/mL

BNCB2226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Colon adenocarcinoma and metastatic adenocarcinoma tissue array

CO953a each
EUR 1434
Description: Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953

Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores

FMG1001 row: 10; column: 10; cores: 100; cases: 96
EUR 258
Description: Breast cancer and breast tissue microarray, contaning 44 cases of invasive carcinoma of no special type, 5 medullary carcinoma, 1 neuroendocrine carcinoma, 37 metastatic invasive carcinoma of no special type, 2 metastatic lobular carcinoma, 1 metastatic medullary carcinoma, 3 breast tissue, 7 adjacent normal breast tissue, single core per block

Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208

UBD208a row: 12; column: 16; cores: 192; cases: 64
EUR 546
Description: Multiple bladder carcinoma with bladder tissue microarray, containing 38 cases of urothelial carcinoma, 6 squamous cell carcinoma, 7 adenocarcinoma, 4 metastatic urothelial carcinoma, 9 bladder tissue, triplicated cores per case

Metastasis-associated in colon cancer protein 1

AP84814 1mg
EUR 2640

Colon cancer with colon tissue array

CO1021a each
EUR 306
Description: Colon cancer with colon tissue array, including pathology grade, with MMR (MLH1/PMS2/MSH2/MSH6) IHC results,TNM and clinical stage, containing 86 cases of adenocarcinoma, 4 papillary adenocarcinoma, 7 mucinous adenocarcinoma, 2 adenoma, 1 congenital megacolon, 2 colon tissue, 102 cases/102 cores replacing CO1021

Colon cancer with colon tissue array

CO1921 each
EUR 546
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 192 cases/192 cores

Colon cancer with colon tissue array

CO2161b each
EUR 474
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 216 cases/216 cores, replacing CO2161a

Colon cancer with colon tissue array

CO721 each
EUR 270
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores

Colon cancer with colon tissue array

CO805 each
EUR 258
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody

abx234920-100ug 100 ug
EUR 610.8

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody

20-abx242861
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody

20-abx104134
  • EUR 543.60
  • EUR 159.60
  • EUR 1579.20
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody

20-abx210666
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody

20-abx210667
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody

20-abx132298
  • EUR 427.20
  • EUR 1111.20
  • EUR 560.40
  • EUR 184.80
  • EUR 326.40
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody

20-abx121640
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody

20-abx325504
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody

20-abx338434
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

MDA-MB-231 Human breast cancer, aggressive/invasive/metastatic cell line: >1x10^10 frozen exosomes

EXOP-105A-1 50 ug
EUR 409

Human Metastasis Associated In Colon Cancer 1 ELISA Kit

IHUMACC1KT each
EUR 799
Description: Human Metastasis Associated In Colon Cancer 1 ELISA Kit

Recombinant Metastasis Associated In Colon Cancer 1 (MACC1)

4-RPM667Hu01
  • EUR 646.85
  • EUR 296.40
  • EUR 2095.68
  • EUR 778.56
  • EUR 1437.12
  • EUR 508.80
  • EUR 5059.20
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Metastasis Associated In Colon Cancer 1 expressed in: E.coli

Recombinant Metastasis Associated In Colon Cancer 1 (MACC1)

RPU42748-100ug 100ug
EUR 603.9

Recombinant Metastasis Associated In Colon Cancer 1 (MACC1)

RPU42748-1mg 1mg
EUR 2675.4

Recombinant Metastasis Associated In Colon Cancer 1 (MACC1)

RPU42748-50ug 50ug
EUR 485.1

Recombinant Metastasis Associated In Colon Cancer 1 (MACC1)

RPM667Hu01 10ug
EUR 196

Recombinant Metastasis Associated In Colon Cancer 1 (MACC1)

RPM667Hu02 10ug
EUR 198

Colon cancer with matched colon tissue array

CO1801a each
EUR 474
Description: Colon cancer with matched colon tissue array, including pathology grade,with MMR (MLH1/PMS2/MSH2/MSH6) IHC results, TNM and clinical stage, containing 90 cases of adenocarcinoma, and 90 cancer adjacent or adjacent normal colon tissue, 90 cases/180 cores, replacing CO1801

Colon cancer with matched colon tissue array

CO602a each
EUR 222
Description: Colon cancer with matched colon tissue array, including pathology grade, TNM and clinical stage, 30 cases/60 cores, replacing CO602

Colon cancer with matched colon tissue array

CO703 each
EUR 198
Description: Colon cancer with matched colon tissue array, including pathology grade, TNM and clinical stage, 35 cases/70 cores,replaced by CO703a

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (HRP)

20-abx336504
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Human Metastasis Associated In Colon Cancer 1 (MACC1) Protein

20-abx068004
  • EUR 895.20
  • EUR 360.00
  • EUR 2815.20
  • EUR 1078.80
  • EUR 644.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (FITC)

20-abx336505
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

ELISA Kit for Metastasis Associated In Colon Cancer 1 (MACC1)

SEM667Hu 96Т
EUR 770

Human Metastasis Associated In Colon Cancer 1 (MACC1) CLIA Kit

20-abx496070
  • EUR 10282.80
  • EUR 5472.00
  • EUR 1262.40
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (Biotin)

20-abx336506
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

20-abx152254
  • EUR 8853.60
  • EUR 4719.60
  • EUR 1093.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

abx251113-96tests 96 tests
EUR 895.2

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

abx572579-96tests 96 tests
EUR 801.6

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

DLR-MACC1-Hu-48T 48T
EUR 664.8
Description: A sandwich quantitative ELISA assay kit for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

DLR-MACC1-Hu-96T 96T
EUR 870
Description: A sandwich quantitative ELISA assay kit for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

SEM667Hu-10x96wellstestplate 10x96-wells test plate
EUR 6227.58
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in serum, plasma, tissue homogenates and other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

SEM667Hu-1x48wellstestplate 1x48-wells test plate
EUR 618.04
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in serum, plasma, tissue homogenates and other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

SEM667Hu-1x96wellstestplate 1x96-wells test plate
EUR 831.48
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in serum, plasma, tissue homogenates and other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

SEM667Hu-5x96wellstestplate 5x96-wells test plate
EUR 3381.66
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in serum, plasma, tissue homogenates and other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

4-SEM667Hu
  • EUR 6288.00
  • EUR 3322.80
  • EUR 831.60
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

EKU05926-48T 48T
EUR 610.82

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

EKU05926-5x96T 5x96T
EUR 4144.85

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

EKU05926-96T 96T
EUR 872.6

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

EKN47037-48T 48T
EUR 416.29

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

EKN47037-5x96T 5x96T
EUR 2824.83

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

EKN47037-96T 96T
EUR 594.7

Human Metastasis Associated In Colon Cancer 1 ELISA Kit (MACC1)

RK01812 96 Tests
EUR 625.2

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

RD-MACC1-Hu-48Tests 48 Tests
EUR 675.6

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

RD-MACC1-Hu-96Tests 96 Tests
EUR 939.6

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

RDR-MACC1-Hu-48Tests 48 Tests
EUR 706.8

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

RDR-MACC1-Hu-96Tests 96 Tests
EUR 984

Human MACC1(Metastasis Associated In Colon Cancer 1) ELISA Kit

ELK6402-48T 48T Ask for price
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MACC1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MACC1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MACC1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MACC1 in the samples is then determined by comparing the OD of the samples to the standard curve.

Human MACC1(Metastasis Associated In Colon Cancer 1) ELISA Kit

ELK6402-96T 96T Ask for price
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MACC1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MACC1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MACC1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MACC1 in the samples is then determined by comparing the OD of the samples to the standard curve.

Human Metastasis Associated In Colon Cancer 1(MACC1)ELISA Kit

QY-E02795 96T
EUR 433.2

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

RDR-MACC1-Hu-48T 48T
EUR 518.18
Description: serum, plasma, tissue homogenates and other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

RDR-MACC1-Hu-96T 96T
EUR 740.25
Description: serum, plasma, tissue homogenates and other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

DL-MACC1-Hu 96T
EUR 481
Description: serum, plasma, tissue homogenates or other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

DLR-MACC1-Hu 96T
EUR 505
Description: serum, plasma, tissue homogenates or other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

RD-MACC1-Hu-48T 48T
EUR 493.5
Description: serum, plasma, tissue homogenates and other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

RD-MACC1-Hu-96T 96T
EUR 705
Description: serum, plasma, tissue homogenates and other biological fluids.

Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit

EK15325 96Т
EUR 768

Melanoma Tissue Array - 12 cases of normal epithelium, nevus, and carcinoma of the skin, and 36 cases of primary (26 cases) and metastatic (10 cases) melanomas in duplicates.

Z7020108 5 slides
EUR 1657.2
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Colon cancer with cancer adjacent tissue array

T051b each
EUR 48
Description: Colon cancer with cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T051a

Colon tissue array with colon cancer tissue

BN05014a each
EUR 222
Description: Colon tissue array with colon cancer tissue, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BN05014

Colon primary cancer with metastatic